Crosstalk between tumor cells and macrophages in stroma renders tumor cells as the primary source of MCP-1/CCL2 in Lewis lung carcinoma

Frontiers in Immunology

Volumn 6, Issue JUN, 2015, Pages

  Yoshimura, Teizo ^a   Liu, Mingyong ^a,b   Chen, Xin ^c,d   Li, Liangzhu ^a,e   Wang, Ji Ming ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c China jack1987168 163com   (Macao)

^d FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Chemokines; Inflammation; Lung cancer; Monocytes macrophages; Tumor microenvironment

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; INFLAMMATION; LEWIS CARCINOMA; MACROPHAGE; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; STROMA; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 84935043372     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00332     Document Type: Article

References (39)

1. Sund M, Kalluri R. Tumor stroma derived biomarkers in cancer. Cancer Metastasis Rev (2009) 28:177-83. doi: 10.1007/s10555-008-9175-2
2. Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer (2007) 7:139-47. doi:10.1038/nrc2067
3. Weiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science (2002) 296:1046-9. doi:10.1126/science.1067431
4. Yoshimura T, Robinson EA, Tanaka S, Appella E, Kuratsu J, Leonard EJ. Purification and amino acid analysis of two human glioma cell-derived monocyte chemoattractants. J Exp Med (1989) 169:1449-59. doi:10.1084/jem.169.4.1449
5. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med (1989) 169:1485-90. doi:10.1084/jem.169.4.1485
6. Bottazzi B, Colotta F, Sica A, Nobili N, Mantovani A. A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). Int J Cancer (1990) 45:795-7. doi:10.1002/ijc.2910450436
7. Bottazzi B, Walter S, Govoni D, Colotta F, Mantovani A. Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J Immunol (1992) 148:1280-5.
8. Hirose K, Hakozaki M, Nyunoya Y, Kobayashi Y, Matsushita K, Takenouchi T, et al. Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration. Br J Cancer (1995) 72:708-14. doi:10.1038/bjc.1995.398
9. Rollins BJ, Sunday ME. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol Cell Biol (1991) 11:3125-31.
10. Yamashiro S, Takeya M, Nishi T, Kuratsu J, Yoshimura T, Ushio Y, et al. Tumor-derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors. Am J Pathol (1994) 145:913-21.
11. Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, et al. Mice deficient in tumor necrosis factor-a are resistant to skin carcinogenesis. Nat Med (1999) 5:828-31. doi:10.1038/10552
12. Popivanova BK, Kostadinova FI, Furuichi K, Shamekh MM, Kondo T, Wada T, et al. Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. Cancer Res (2009) 69:7884-92. doi:10.1158/0008-5472.CAN-09-1451
13. Loberg RD, Ying C, Craig M, Day LL, Sargent E, Neeley C, et al. Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. Cancer Res (2007) 67:9417-24. doi:10.1158/0008-5472.CAN-07-1286
14. Lu Y, Cai Z, Xiao G, Keller ET, Mizokami A, Yao Z, et al. Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption. Cancer Res (2007) 67:3646-53. doi:10.1158/0008-5472.CAN-06-1210
15. Li X, Loberg R, Liao J, Ying C, Snyder LA, Pienta KJ, et al. A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone. Cancer Res (2009) 69:1685-92. doi:10.1158/0008-5472.CAN-08-2164
16. Fridlender ZG, Kapoor V, Buchlis G, Cheng G, Sun J, Wang LC, et al. CCL2 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells. Am J Respir Cell Mol Biol (2011) 44:230-7. doi:10.1165/rcmb.2010-0080OC
17. Lu X, Kang Y. Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J Biol Chem (2009) 284:29087-96. doi:10.1074/jbc.M109.035899
18. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature (2011) 475:222-5. doi:10.1038/nature10138
19. Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Strom SR, Burdick MD, et al. Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines. Cancer Immunol Immunother (2000) 49:63-70. doi:10.1007/s002620050603
20. Zhang XW, Qin X, Qin CY, Yin YL, Chen Y, Zhu H. Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance. Cancer Immunol Immunother (2012) 62:563-70. doi:10.1007/s00262-012-1361-y
21. Bertram JS, Janik P. Establishment of a cloned line of Lewis lung carcinoma cells adapted to cell culture. Cancer Lett (1980) 11:63-73. doi:10.1016/0304-3835(80)90130-5
22. Stathopoulos GT, Psallidas I, Moustaki A, Moschos C, Kollintza A, Karabela S, et al. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion. J Natl Cancer Inst (2008) 100:1464-76. doi:10.1093/jnci/djn325
23. Yoshimura T, Howard OMZ, Ito T, Kuwabara M, Matsukawa A, Chen K, et al. Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PLoS One (2013) 8:e58791. doi:10.1371/journal.pone.0058791
24. Garber K. First results for agents targeting cancer-related inflammation. J Natl Cancer Inst (2010) 101:1110-2. doi:10.1093/jnci/djp266
25. Pienta KJ, Machiels JP, Schrijvers D, Alekseev B, Shkolnik M, Crabb SJ, et al. Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer. Invest New Drugs (2012) 31:760-8. doi:10.1007/s10637-012-9869-8
26. Sandhu SK, Papadopoulos K, Fong PC, Patnaik A, Messiou C, Olmos D, et al. A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors. Cancer Chemother Pharmacol (2013) 71(4):1041-50. doi:10.1007/s00280-013-2099-8
27. Redon CE, Dickey JS, Nakamura AJ, Kareva IG, Naf D, Nowsheen S, et al. Tumors induce complex DNA damage in distant proliferative tissues in vivo. Proc Natl Acad Sci U S A (2011) 107:17992-7. doi:10.1073/pnas.1008260107
28. Takahashi M, Galligan C, Tessarollo L, Yoshimura T. Monocyte chemoattractant protein-1 (MCP-1), not MCP-3, is the primary chemokine required for monocyte recruitment in mouse peritonitis induced with thioglycollate or zymosan A. J Immunol (2009) 183:3463-71. doi:10.4049/jimmunol.0802812
29. Yoshimura T, Galligan C, Takahashi M, Chen K, Liu M, Tessarollo L, et al. Non-myeloid cells are major contributors to innate immune responses via production of monocyte chemoattractant protein-1/CCL2. Front Immunol (2014) 4:482. doi:10.3389/fimmu.2013.00482
30. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophage and granulocytes using LysMcre mice. Transgenic Res (1999) 8:265-77. doi:10.1023/A:1008942828960
31. Yoshimura T, Johnson DG. cDNA cloning and expression of guinea pig neutrophil attractant protein-1 (NAP-1): NAP-1 is highly conserved in guinea pig. J Immunol (1993) 151:6225-36.
32. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol (2008) 26:317-25. doi:10.1038/nbt1385
33. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, Kim Y, et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature (2009) 457:102-6. doi:10.1038/nature07623
34. Zhang J, Lu Y, Pienta KJ. Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth. J Natl Cancer Inst (2010) 102:522-8. doi:10.1093/jnci/djq044
35. Ben-Baruch A. The tumor-promoting flow of cells into, within and out of the tumor site: regulation by the inflammatory axis of TNFa and chemokines. Cancer Microenviron (2012) 5:151-64. doi:10.1007/s12307-011-0094-3
36. Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest (2008) 118:560-70. doi:10.1172/JCI32453
37. Cordero JB, Macagno JP, Stefanatos RK, Strathdee KE, Cagan RL, Vidal M. Oncogenic Ras diverts a host TNF tumor suppressor activity into tumor promoter. Dev Cell (2010) 18:999-1011. doi:10.1016/j.devcel.2010.05.014
38. Standiford TJ, Kunkel SL, Phan SH, Rollins BJ, Strieter RM. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem (1991) 266:9912-8.
39. Weiss ID, Ella E, Dominsky O, Smith Y, Abraham M, Wald H, et al. In the hunt for therapeutic targets: mimicking the growth, metastasis, and stromal associations of early-stage lung cancer using a novel orthotopic animal model. J Thorac Oncol (2015) 10:46-58. doi:10.1097/JTO.0000000000000367